Tau Therapeutics
About Us
|
Products
|
Research & Development
|
For Patients
|
Media
|
Home
Products
Mibefradil Dihydrochloride
TTL-1177
Tau’s proprietary lead compound, TTL-1177, is in pre-clinical testing.
